CA2462660A1 - Nucleic acid-associated proteins - Google Patents

Nucleic acid-associated proteins Download PDF

Info

Publication number: CA2462660A1
Authority: CA; Canada
Prior art keywords: seq; polynucleotide; polypeptide; amino acid; acid sequence
Prior art date: 2001-10-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002462660A

Other languages

English (en)

French (fr)

Inventor

Shanya Becha

Mark L. Borowsky

Neil Burford

Narinder K. Chawla

Vicki S. Elliott

Brooke M. Emerling

Ian J. Forsythe

Kimberly J. Gietzen

Ann E. Gorvad

Jennifer A. Griffin

April J. A. Hafalia

Craig H. Ison

Preeti G. Lal

Ernestine A. Lee

Sally Lee

Soo Yeun Lee

Joseph P. Marquis

Jayalaxmi Ramkumar

William W. Sprague

Anita Swarnakar

Y. Tom Tang

Bridget A. Warren

Junming Yang

Henry Yue

Yeganeh Zebarjadian

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Incyte Genomics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-29

Filing date

2002-10-29

Publication date

2003-05-08

2002-10-29 Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc

2003-05-08 Publication of CA2462660A1 publication Critical patent/CA2462660A1/en

Status Abandoned legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 93
102000039446 nucleic acids Human genes 0.000 title claims abstract description 69
108020004707 nucleic acids Proteins 0.000 title claims abstract description 69
108090000623 proteins and genes Proteins 0.000 title abstract description 244
102000004169 proteins and genes Human genes 0.000 title abstract description 143
102000040430 polynucleotide Human genes 0.000 claims abstract description 400
108091033319 polynucleotide Proteins 0.000 claims abstract description 400
239000002157 polynucleotide Substances 0.000 claims abstract description 400
238000000034 method Methods 0.000 claims abstract description 163
230000014509 gene expression Effects 0.000 claims abstract description 101
239000000556 agonist Substances 0.000 claims abstract description 15
239000005557 antagonist Substances 0.000 claims abstract description 11
108090000765 processed proteins & peptides Proteins 0.000 claims description 304
102000004196 processed proteins & peptides Human genes 0.000 claims description 294
229920001184 polypeptide Polymers 0.000 claims description 291
125000003275 alpha amino acid group Chemical group 0.000 claims description 168
210000004027 cell Anatomy 0.000 claims description 147
239000012634 fragment Substances 0.000 claims description 114
150000001875 compounds Chemical class 0.000 claims description 88
125000003729 nucleotide group Chemical group 0.000 claims description 75
239000002773 nucleotide Substances 0.000 claims description 73
230000000694 effects Effects 0.000 claims description 64
239000000523 sample Substances 0.000 claims description 61
230000027455 binding Effects 0.000 claims description 50
238000009739 binding Methods 0.000 claims description 50
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 47
238000009396 hybridization Methods 0.000 claims description 40
238000012360 testing method Methods 0.000 claims description 39
239000000203 mixture Substances 0.000 claims description 38
201000010099 disease Diseases 0.000 claims description 35
230000000295 complement effect Effects 0.000 claims description 31
230000015572 biosynthetic process Effects 0.000 claims description 25
108091034117 Oligonucleotide Proteins 0.000 claims description 22
239000000758 substrate Substances 0.000 claims description 21
238000012216 screening Methods 0.000 claims description 20
230000002163 immunogen Effects 0.000 claims description 18
241001465754 Metazoa Species 0.000 claims description 17
239000012472 biological sample Substances 0.000 claims description 15
238000011282 treatment Methods 0.000 claims description 15
238000004519 manufacturing process Methods 0.000 claims description 14
238000002493 microarray Methods 0.000 claims description 12
230000009870 specific binding Effects 0.000 claims description 11
230000003247 decreasing effect Effects 0.000 claims description 9
230000008859 change Effects 0.000 claims description 8
230000009261 transgenic effect Effects 0.000 claims description 8
239000000546 pharmaceutical excipient Substances 0.000 claims description 7
230000002018 overexpression Effects 0.000 claims description 6
239000007787 solid Substances 0.000 claims description 6
238000012408 PCR amplification Methods 0.000 claims description 5
230000001988 toxicity Effects 0.000 claims description 5
231100000419 toxicity Toxicity 0.000 claims description 5
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 4
238000012258 culturing Methods 0.000 claims description 3
230000003053 immunization Effects 0.000 claims description 3
238000002372 labelling Methods 0.000 claims description 3
108060003951 Immunoglobulin Proteins 0.000 claims description 2
102000018358 immunoglobulin Human genes 0.000 claims description 2
101000757260 Patiria pectinifera Nucleoplasmin-like protein ANO39 Proteins 0.000 claims 6
230000005875 antibody response Effects 0.000 claims 2
210000000628 antibody-producing cell Anatomy 0.000 claims 2
210000004408 hybridoma Anatomy 0.000 claims 2
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims 1
238000002405 diagnostic procedure Methods 0.000 claims 1
241000282414 Homo sapiens Species 0.000 abstract description 51
239000013604 expression vector Substances 0.000 abstract description 16
230000001594 aberrant effect Effects 0.000 abstract description 2
235000018102 proteins Nutrition 0.000 description 128
108010053770 Deoxyribonucleases Proteins 0.000 description 100
102000016911 Deoxyribonucleases Human genes 0.000 description 100
235000001014 amino acid Nutrition 0.000 description 53
230000006870 function Effects 0.000 description 50
229940024606 amino acid Drugs 0.000 description 44
150000001413 amino acids Chemical class 0.000 description 44
108020004566 Transfer RNA Proteins 0.000 description 41
229940088598 enzyme Drugs 0.000 description 40
108020004999 messenger RNA Proteins 0.000 description 40
102000004190 Enzymes Human genes 0.000 description 39
108090000790 Enzymes Proteins 0.000 description 39
230000014616 translation Effects 0.000 description 39
230000008569 process Effects 0.000 description 31
238000013519 translation Methods 0.000 description 31
239000013615 primer Substances 0.000 description 29
108091028043 Nucleic acid sequence Proteins 0.000 description 28
238000002869 basic local alignment search tool Methods 0.000 description 28
230000001105 regulatory effect Effects 0.000 description 28
210000001519 tissue Anatomy 0.000 description 28
238000006467 substitution reaction Methods 0.000 description 26
238000013518 transcription Methods 0.000 description 26
230000035897 transcription Effects 0.000 description 26
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 25
239000011701 zinc Substances 0.000 description 25
229910052725 zinc Inorganic materials 0.000 description 25
206010028980 Neoplasm Diseases 0.000 description 24
239000013598 vector Substances 0.000 description 24
238000004458 analytical method Methods 0.000 description 23
230000035772 mutation Effects 0.000 description 23
238000011161 development Methods 0.000 description 22
230000018109 developmental process Effects 0.000 description 22
102000040945 Transcription factor Human genes 0.000 description 21
108091023040 Transcription factor Proteins 0.000 description 21
239000002299 complementary DNA Substances 0.000 description 21
238000003752 polymerase chain reaction Methods 0.000 description 20
208000026310 Breast neoplasm Diseases 0.000 description 18
240000004808 Saccharomyces cerevisiae Species 0.000 description 18
238000004422 calculation algorithm Methods 0.000 description 18
239000003446 ligand Substances 0.000 description 18
108010000605 Ribosomal Proteins Proteins 0.000 description 17
102000002278 Ribosomal Proteins Human genes 0.000 description 17
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 17
239000003623 enhancer Substances 0.000 description 17
206010006187 Breast cancer Diseases 0.000 description 15
102000053602 DNA Human genes 0.000 description 15
238000003786 synthesis reaction Methods 0.000 description 15
108020004414 DNA Proteins 0.000 description 14
125000000539 amino acid group Chemical group 0.000 description 14
201000011510 cancer Diseases 0.000 description 14
230000006798 recombination Effects 0.000 description 14
238000003556 assay Methods 0.000 description 13
238000000338 in vitro Methods 0.000 description 13
102000005962 receptors Human genes 0.000 description 13
108020003175 receptors Proteins 0.000 description 13
230000004568 DNA-binding Effects 0.000 description 12
101710183280 Topoisomerase Proteins 0.000 description 12
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 12
210000000349 chromosome Anatomy 0.000 description 12
208000035475 disorder Diseases 0.000 description 12
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
230000004048 modification Effects 0.000 description 12
238000012986 modification Methods 0.000 description 12
230000010076 replication Effects 0.000 description 12
102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 11
108091023037 Aptamer Proteins 0.000 description 11
108700024394 Exon Proteins 0.000 description 11
108060004795 Methyltransferase Proteins 0.000 description 11
241000699666 Mus <mouse, genus> Species 0.000 description 11
108010026552 Proteome Proteins 0.000 description 11
230000033228 biological regulation Effects 0.000 description 11
238000012217 deletion Methods 0.000 description 11
230000037430 deletion Effects 0.000 description 11
238000005516 engineering process Methods 0.000 description 11
208000015181 infectious disease Diseases 0.000 description 11
238000012545 processing Methods 0.000 description 11
238000005215 recombination Methods 0.000 description 11
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 10
108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 10
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 10
230000003197 catalytic effect Effects 0.000 description 10
239000003550 marker Substances 0.000 description 10
108020004705 Codon Proteins 0.000 description 9
108091035707 Consensus sequence Proteins 0.000 description 9
102000003915 DNA Topoisomerases Human genes 0.000 description 9
108090000323 DNA Topoisomerases Proteins 0.000 description 9
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 9
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 9
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 9
229940123464 Thiazolidinedione Drugs 0.000 description 9
230000004913 activation Effects 0.000 description 9
238000007792 addition Methods 0.000 description 9
238000003776 cleavage reaction Methods 0.000 description 9
230000000875 corresponding effect Effects 0.000 description 9
230000004069 differentiation Effects 0.000 description 9
108020001507 fusion proteins Proteins 0.000 description 9
102000037865 fusion proteins Human genes 0.000 description 9
230000028993 immune response Effects 0.000 description 9
230000000977 initiatory effect Effects 0.000 description 9
-1 ribonucleotide triphosphates Chemical class 0.000 description 9
108020004418 ribosomal RNA Proteins 0.000 description 9
150000001467 thiazolidinediones Chemical class 0.000 description 9
208000001072 type 2 diabetes mellitus Diseases 0.000 description 9
241000894006 Bacteria Species 0.000 description 8
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 8
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 8
241000124008 Mammalia Species 0.000 description 8
208000008589 Obesity Diseases 0.000 description 8
108060008682 Tumor Necrosis Factor Proteins 0.000 description 8
230000003321 amplification Effects 0.000 description 8
230000006907 apoptotic process Effects 0.000 description 8
230000010261 cell growth Effects 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
235000018417 cysteine Nutrition 0.000 description 8
230000002068 genetic effect Effects 0.000 description 8
238000003780 insertion Methods 0.000 description 8
230000037431 insertion Effects 0.000 description 8
230000007246 mechanism Effects 0.000 description 8
230000001404 mediated effect Effects 0.000 description 8
238000003199 nucleic acid amplification method Methods 0.000 description 8
210000004940 nucleus Anatomy 0.000 description 8
235000020824 obesity Nutrition 0.000 description 8
230000007017 scission Effects 0.000 description 8
238000012163 sequencing technique Methods 0.000 description 8
241000894007 species Species 0.000 description 8
230000002103 transcriptional effect Effects 0.000 description 8
108091026890 Coding region Proteins 0.000 description 7
241000196324 Embryophyta Species 0.000 description 7
108090001093 Lymphoid enhancer-binding factor 1 Proteins 0.000 description 7
102000039471 Small Nuclear RNA Human genes 0.000 description 7
102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 description 7
108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 description 7
230000011759 adipose tissue development Effects 0.000 description 7
230000000692 anti-sense effect Effects 0.000 description 7
210000004899 c-terminal region Anatomy 0.000 description 7
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 7
210000004443 dendritic cell Anatomy 0.000 description 7
230000001419 dependent effect Effects 0.000 description 7
206010012601 diabetes mellitus Diseases 0.000 description 7
238000003745 diagnosis Methods 0.000 description 7
210000004265 eukaryotic small ribosome subunit Anatomy 0.000 description 7
230000001965 increasing effect Effects 0.000 description 7
208000020816 lung neoplasm Diseases 0.000 description 7
239000012528 membrane Substances 0.000 description 7
210000004379 membrane Anatomy 0.000 description 7
230000026731 phosphorylation Effects 0.000 description 7
238000006366 phosphorylation reaction Methods 0.000 description 7
238000011160 research Methods 0.000 description 7
210000003705 ribosome Anatomy 0.000 description 7
108091029842 small nuclear ribonucleic acid Proteins 0.000 description 7
239000000243 solution Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
230000003612 virological effect Effects 0.000 description 7
206010003594 Ataxia telangiectasia Diseases 0.000 description 6
102000014914 Carrier Proteins Human genes 0.000 description 6
108010077544 Chromatin Proteins 0.000 description 6
206010009944 Colon cancer Diseases 0.000 description 6
208000001333 Colorectal Neoplasms Diseases 0.000 description 6
230000033616 DNA repair Effects 0.000 description 6
241000206602 Eukaryota Species 0.000 description 6
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 6
101000852214 Homo sapiens THO complex subunit 4 Proteins 0.000 description 6
206010061218 Inflammation Diseases 0.000 description 6
108090001061 Insulin Proteins 0.000 description 6
102000004877 Insulin Human genes 0.000 description 6
206010058467 Lung neoplasm malignant Diseases 0.000 description 6
102000007999 Nuclear Proteins Human genes 0.000 description 6
108010089610 Nuclear Proteins Proteins 0.000 description 6
108091093037 Peptide nucleic acid Proteins 0.000 description 6
108091081024 Start codon Proteins 0.000 description 6
102100036434 THO complex subunit 4 Human genes 0.000 description 6
239000000427 antigen Substances 0.000 description 6
108091007433 antigens Proteins 0.000 description 6
102000036639 antigens Human genes 0.000 description 6
230000001580 bacterial effect Effects 0.000 description 6
230000001413 cellular effect Effects 0.000 description 6
210000003483 chromatin Anatomy 0.000 description 6
230000001086 cytosolic effect Effects 0.000 description 6
230000034994 death Effects 0.000 description 6
231100000517 death Toxicity 0.000 description 6
239000003814 drug Substances 0.000 description 6
210000002919 epithelial cell Anatomy 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
230000004054 inflammatory process Effects 0.000 description 6
229940125396 insulin Drugs 0.000 description 6
201000005202 lung cancer Diseases 0.000 description 6
230000011987 methylation Effects 0.000 description 6
238000007069 methylation reaction Methods 0.000 description 6
230000037361 pathway Effects 0.000 description 6
239000013612 plasmid Substances 0.000 description 6
239000002243 precursor Substances 0.000 description 6
239000002987 primer (paints) Substances 0.000 description 6
239000000047 product Substances 0.000 description 6
230000002062 proliferating effect Effects 0.000 description 6
238000001243 protein synthesis Methods 0.000 description 6
238000000746 purification Methods 0.000 description 6
235000000346 sugar Nutrition 0.000 description 6
230000009466 transformation Effects 0.000 description 6
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 5
208000023275 Autoimmune disease Diseases 0.000 description 5
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
206010022489 Insulin Resistance Diseases 0.000 description 5
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
102100022699 Lymphoid enhancer-binding factor 1 Human genes 0.000 description 5
102000002151 Microfilament Proteins Human genes 0.000 description 5
102000015636 Oligopeptides Human genes 0.000 description 5
108010038807 Oligopeptides Proteins 0.000 description 5
206010061535 Ovarian neoplasm Diseases 0.000 description 5
108090000944 RNA Helicases Proteins 0.000 description 5
102000004409 RNA Helicases Human genes 0.000 description 5
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
102100040247 Tumor necrosis factor Human genes 0.000 description 5
108091023045 Untranslated Region Proteins 0.000 description 5
241000251539 Vertebrata <Metazoa> Species 0.000 description 5
101150093411 ZNF143 gene Proteins 0.000 description 5
101710185494 Zinc finger protein Proteins 0.000 description 5
102100023597 Zinc finger protein 816 Human genes 0.000 description 5
108091008324 binding proteins Proteins 0.000 description 5
230000004071 biological effect Effects 0.000 description 5
210000000481 breast Anatomy 0.000 description 5
231100000504 carcinogenesis Toxicity 0.000 description 5
208000029742 colonic neoplasm Diseases 0.000 description 5
230000002950 deficient Effects 0.000 description 5
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 5
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 5
230000013595 glycosylation Effects 0.000 description 5
238000006206 glycosylation reaction Methods 0.000 description 5
230000007062 hydrolysis Effects 0.000 description 5
238000006460 hydrolysis reaction Methods 0.000 description 5
230000001939 inductive effect Effects 0.000 description 5
239000003999 initiator Substances 0.000 description 5
230000003993 interaction Effects 0.000 description 5
210000004185 liver Anatomy 0.000 description 5
238000013507 mapping Methods 0.000 description 5
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 5
230000008488 polyadenylation Effects 0.000 description 5
210000000229 preadipocyte Anatomy 0.000 description 5
230000004044 response Effects 0.000 description 5
238000002864 sequence alignment Methods 0.000 description 5
230000011664 signaling Effects 0.000 description 5
235000019333 sodium laurylsulphate Nutrition 0.000 description 5
208000011580 syndromic disease Diseases 0.000 description 5
230000032258 transport Effects 0.000 description 5
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
108020004635 Complementary DNA Proteins 0.000 description 4
102000004127 Cytokines Human genes 0.000 description 4
108090000695 Cytokines Proteins 0.000 description 4
108090000133 DNA helicases Proteins 0.000 description 4
102000003844 DNA helicases Human genes 0.000 description 4
208000012239 Developmental disease Diseases 0.000 description 4
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
101100232687 Drosophila melanogaster eIF4A gene Proteins 0.000 description 4
241000588724 Escherichia coli Species 0.000 description 4
101710091919 Eukaryotic translation initiation factor 4G Proteins 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
102000015779 HDL Lipoproteins Human genes 0.000 description 4
108010010234 HDL Lipoproteins Proteins 0.000 description 4
101710154606 Hemagglutinin Proteins 0.000 description 4
241000711549 Hepacivirus C Species 0.000 description 4
102000009331 Homeodomain Proteins Human genes 0.000 description 4
108010048671 Homeodomain Proteins Proteins 0.000 description 4
241000282412 Homo Species 0.000 description 4
101000988394 Homo sapiens PDZ and LIM domain protein 5 Proteins 0.000 description 4
101000759226 Homo sapiens Zinc finger protein 143 Proteins 0.000 description 4
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
239000004472 Lysine Substances 0.000 description 4
108010040897 Microfilament Proteins Proteins 0.000 description 4
101710163270 Nuclease Proteins 0.000 description 4
101710093908 Outer capsid protein VP4 Proteins 0.000 description 4
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 4
206010033128 Ovarian cancer Diseases 0.000 description 4
101710176177 Protein A56 Proteins 0.000 description 4
238000012300 Sequence Analysis Methods 0.000 description 4
208000001163 Tangier disease Diseases 0.000 description 4
102100035559 Transcriptional activator GLI3 Human genes 0.000 description 4
108700025716 Tumor Suppressor Genes Proteins 0.000 description 4
102000044209 Tumor Suppressor Genes Human genes 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
208000036142 Viral infection Diseases 0.000 description 4
102100023389 Zinc finger protein 143 Human genes 0.000 description 4
238000000137 annealing Methods 0.000 description 4
230000000890 antigenic effect Effects 0.000 description 4
238000003491 array Methods 0.000 description 4
230000001363 autoimmune Effects 0.000 description 4
210000004556 brain Anatomy 0.000 description 4
230000024245 cell differentiation Effects 0.000 description 4
230000004663 cell proliferation Effects 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000001514 detection method Methods 0.000 description 4
239000003862 glucocorticoid Substances 0.000 description 4
230000012010 growth Effects 0.000 description 4
239000000185 hemagglutinin Substances 0.000 description 4
230000003301 hydrolyzing effect Effects 0.000 description 4
208000027866 inflammatory disease Diseases 0.000 description 4
239000003112 inhibitor Substances 0.000 description 4
210000000265 leukocyte Anatomy 0.000 description 4
239000000463 material Substances 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
230000004060 metabolic process Effects 0.000 description 4
229930182817 methionine Natural products 0.000 description 4
230000002438 mitochondrial effect Effects 0.000 description 4
230000000926 neurological effect Effects 0.000 description 4
239000002245 particle Substances 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
230000003389 potentiating effect Effects 0.000 description 4
230000028327 secretion Effects 0.000 description 4
150000003384 small molecules Chemical class 0.000 description 4
210000000952 spleen Anatomy 0.000 description 4
210000001550 testis Anatomy 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
210000001541 thymus gland Anatomy 0.000 description 4
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 4
241001430294 unidentified retrovirus Species 0.000 description 4
238000011144 upstream manufacturing Methods 0.000 description 4
230000009385 viral infection Effects 0.000 description 4
102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
101150067361 Aars1 gene Proteins 0.000 description 3
101001082110 Acanthamoeba polyphaga mimivirus Eukaryotic translation initiation factor 4E homolog Proteins 0.000 description 3
239000004475 Arginine Substances 0.000 description 3
201000001320 Atherosclerosis Diseases 0.000 description 3
241000972773 Aulopiformes Species 0.000 description 3
208000031212 Autoimmune polyendocrinopathy Diseases 0.000 description 3
108060000903 Beta-catenin Proteins 0.000 description 3
101150013553 CD40 gene Proteins 0.000 description 3
108010043471 Core Binding Factor Alpha 2 Subunit Proteins 0.000 description 3
230000004543 DNA replication Effects 0.000 description 3
238000001712 DNA sequencing Methods 0.000 description 3
101710096438 DNA-binding protein Proteins 0.000 description 3
101001082109 Danio rerio Eukaryotic translation initiation factor 4E-1B Proteins 0.000 description 3
108010008165 Etanercept Proteins 0.000 description 3
108060002716 Exonuclease Proteins 0.000 description 3
102000004315 Forkhead Transcription Factors Human genes 0.000 description 3
108090000852 Forkhead Transcription Factors Proteins 0.000 description 3
102000030782 GTP binding Human genes 0.000 description 3
108091000058 GTP-Binding Proteins 0.000 description 3
102000005720 Glutathione transferase Human genes 0.000 description 3
108010070675 Glutathione transferase Proteins 0.000 description 3
102000006479 Heterogeneous-Nuclear Ribonucleoproteins Human genes 0.000 description 3
108010019372 Heterogeneous-Nuclear Ribonucleoproteins Proteins 0.000 description 3
241000238631 Hexapoda Species 0.000 description 3
206010020772 Hypertension Diseases 0.000 description 3
102100034343 Integrase Human genes 0.000 description 3
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
102000019298 Lipocalin Human genes 0.000 description 3
108050006654 Lipocalin Proteins 0.000 description 3
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 3
206010027476 Metastases Diseases 0.000 description 3
102100037517 Metastasis-associated protein MTA1 Human genes 0.000 description 3
241001529936 Murinae Species 0.000 description 3
206010061309 Neoplasm progression Diseases 0.000 description 3
102000014736 Notch Human genes 0.000 description 3
108010070047 Notch Receptors Proteins 0.000 description 3
108091005461 Nucleic proteins Proteins 0.000 description 3
108010047956 Nucleosomes Proteins 0.000 description 3
102100029181 PDZ and LIM domain protein 5 Human genes 0.000 description 3
208000002193 Pain Diseases 0.000 description 3
102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 3
108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
108010091086 Recombinases Proteins 0.000 description 3
102000018120 Recombinases Human genes 0.000 description 3
102000004389 Ribonucleoproteins Human genes 0.000 description 3
108010081734 Ribonucleoproteins Proteins 0.000 description 3
108091028664 Ribonucleotide Proteins 0.000 description 3
102100025373 Runt-related transcription factor 1 Human genes 0.000 description 3
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
206010041067 Small cell lung cancer Diseases 0.000 description 3
208000006011 Stroke Diseases 0.000 description 3
210000001744 T-lymphocyte Anatomy 0.000 description 3
102100036407 Thioredoxin Human genes 0.000 description 3
241000723873 Tobacco mosaic virus Species 0.000 description 3
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 3
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 3
102000007537 Type II DNA Topoisomerases Human genes 0.000 description 3
108010046308 Type II DNA Topoisomerases Proteins 0.000 description 3
241000700618 Vaccinia virus Species 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
230000005856 abnormality Effects 0.000 description 3
230000003213 activating effect Effects 0.000 description 3
210000001789 adipocyte Anatomy 0.000 description 3
210000000577 adipose tissue Anatomy 0.000 description 3
239000002246 antineoplastic agent Substances 0.000 description 3
229940041181 antineoplastic drug Drugs 0.000 description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
210000003719 b-lymphocyte Anatomy 0.000 description 3
230000008827 biological function Effects 0.000 description 3
210000002459 blastocyst Anatomy 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
150000001720 carbohydrates Chemical class 0.000 description 3
235000014633 carbohydrates Nutrition 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
210000001072 colon Anatomy 0.000 description 3
210000000805 cytoplasm Anatomy 0.000 description 3
229960003957 dexamethasone Drugs 0.000 description 3
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
238000006471 dimerization reaction Methods 0.000 description 3
229940079593 drug Drugs 0.000 description 3
210000002889 endothelial cell Anatomy 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
102000013165 exonuclease Human genes 0.000 description 3
239000000284 extract Substances 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 3
238000002744 homologous recombination Methods 0.000 description 3
230000006801 homologous recombination Effects 0.000 description 3
229940088597 hormone Drugs 0.000 description 3
239000005556 hormone Substances 0.000 description 3
210000000688 human artificial chromosome Anatomy 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
239000001257 hydrogen Substances 0.000 description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
230000006698 induction Effects 0.000 description 3
230000005764 inhibitory process Effects 0.000 description 3
208000014674 injury Diseases 0.000 description 3
210000000936 intestine Anatomy 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
210000002540 macrophage Anatomy 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
230000035800 maturation Effects 0.000 description 3
208000002154 non-small cell lung carcinoma Diseases 0.000 description 3
210000001623 nucleosome Anatomy 0.000 description 3
210000003463 organelle Anatomy 0.000 description 3
230000008506 pathogenesis Effects 0.000 description 3
238000000059 patterning Methods 0.000 description 3
230000002093 peripheral effect Effects 0.000 description 3
238000006116 polymerization reaction Methods 0.000 description 3
102000054765 polymorphisms of proteins Human genes 0.000 description 3
230000002265 prevention Effects 0.000 description 3
230000000750 progressive effect Effects 0.000 description 3
230000001737 promoting effect Effects 0.000 description 3
210000002307 prostate Anatomy 0.000 description 3
108010014186 ras Proteins Proteins 0.000 description 3
230000008439 repair process Effects 0.000 description 3
238000012552 review Methods 0.000 description 3
239000002336 ribonucleotide Substances 0.000 description 3
235000019515 salmon Nutrition 0.000 description 3
230000001235 sensitizing effect Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
230000019491 signal transduction Effects 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
108060008226 thioredoxin Proteins 0.000 description 3
238000012546 transfer Methods 0.000 description 3
230000014621 translational initiation Effects 0.000 description 3
230000005945 translocation Effects 0.000 description 3
230000005751 tumor progression Effects 0.000 description 3
208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 3
241000701161 unidentified adenovirus Species 0.000 description 3
239000004474 valine Substances 0.000 description 3
238000005406 washing Methods 0.000 description 3
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
108091006112 ATPases Proteins 0.000 description 2
102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
102000000412 Annexin Human genes 0.000 description 2
108050008874 Annexin Proteins 0.000 description 2
108020005098 Anticodon Proteins 0.000 description 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
102100036465 Autoimmune regulator Human genes 0.000 description 2
102000015735 Beta-catenin Human genes 0.000 description 2
208000005692 Bloom Syndrome Diseases 0.000 description 2
241000244203 Caenorhabditis elegans Species 0.000 description 2
101100011370 Caenorhabditis elegans egl-27 gene Proteins 0.000 description 2
102000000584 Calmodulin Human genes 0.000 description 2
108010041952 Calmodulin Proteins 0.000 description 2
208000005623 Carcinogenesis Diseases 0.000 description 2
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 2
102000017589 Chromo domains Human genes 0.000 description 2
108050005811 Chromo domains Proteins 0.000 description 2
102000011591 Cleavage And Polyadenylation Specificity Factor Human genes 0.000 description 2
108010076130 Cleavage And Polyadenylation Specificity Factor Proteins 0.000 description 2
102000005221 Cleavage Stimulation Factor Human genes 0.000 description 2
108010081236 Cleavage Stimulation Factor Proteins 0.000 description 2
108700010070 Codon Usage Proteins 0.000 description 2
208000035473 Communicable disease Diseases 0.000 description 2
MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
241000192700 Cyanobacteria Species 0.000 description 2
NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
230000005778 DNA damage Effects 0.000 description 2
231100000277 DNA damage Toxicity 0.000 description 2
AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
102000001301 EGF receptor Human genes 0.000 description 2
108060006698 EGF receptor Proteins 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
241001635598 Enicostema Species 0.000 description 2
101150099271 FHIT gene Proteins 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
241000233866 Fungi Species 0.000 description 2
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
102100024977 Glutamine-tRNA ligase Human genes 0.000 description 2
239000004471 Glycine Substances 0.000 description 2
108020004996 Heterogeneous Nuclear RNA Proteins 0.000 description 2
108700005087 Homeobox Genes Proteins 0.000 description 2
101000928549 Homo sapiens Autoimmune regulator Proteins 0.000 description 2
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 2
101001018431 Homo sapiens DNA replication licensing factor MCM7 Proteins 0.000 description 2
101001027925 Homo sapiens Metastasis-associated protein MTA1 Proteins 0.000 description 2
101001128495 Homo sapiens Myeloid zinc finger 1 Proteins 0.000 description 2
101000702545 Homo sapiens Transcription activator BRG1 Proteins 0.000 description 2
101000641003 Homo sapiens Tyrosine-tRNA ligase, cytoplasmic Proteins 0.000 description 2
101000788997 Homo sapiens Tyrosine-tRNA ligase, mitochondrial Proteins 0.000 description 2
208000026350 Inborn Genetic disease Diseases 0.000 description 2
101710203526 Integrase Proteins 0.000 description 2
102000004388 Interleukin-4 Human genes 0.000 description 2
108090000978 Interleukin-4 Proteins 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
102000003960 Ligases Human genes 0.000 description 2
108090000364 Ligases Proteins 0.000 description 2
102000004857 Lymphoid enhancer-binding factor 1 Human genes 0.000 description 2
206010064912 Malignant transformation Diseases 0.000 description 2
208000003250 Mixed connective tissue disease Diseases 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
102100031827 Myeloid zinc finger 1 Human genes 0.000 description 2
102000003945 NF-kappa B Human genes 0.000 description 2
108010057466 NF-kappa B Proteins 0.000 description 2
241000208125 Nicotiana Species 0.000 description 2
235000002637 Nicotiana tabacum Nutrition 0.000 description 2
102000007399 Nuclear hormone receptor Human genes 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
108700026244 Open Reading Frames Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
108010016731 PPAR gamma Proteins 0.000 description 2
108010044843 Peptide Initiation Factors Proteins 0.000 description 2
102000005877 Peptide Initiation Factors Human genes 0.000 description 2
102100021698 Peregrin Human genes 0.000 description 2
102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 2
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
101710124239 Poly(A) polymerase Proteins 0.000 description 2
108010041472 Poly(A)-Binding Protein II Proteins 0.000 description 2
108010029485 Protein Isoforms Proteins 0.000 description 2
102000001708 Protein Isoforms Human genes 0.000 description 2
108091034057 RNA (poly(A)) Proteins 0.000 description 2
230000004570 RNA-binding Effects 0.000 description 2
241000700159 Rattus Species 0.000 description 2
108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
108091027981 Response element Proteins 0.000 description 2
102000034527 Retinoid X Receptors Human genes 0.000 description 2
108010038912 Retinoid X Receptors Proteins 0.000 description 2
102000006382 Ribonucleases Human genes 0.000 description 2
108010083644 Ribonucleases Proteins 0.000 description 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
102100024908 Ribosomal protein S6 kinase beta-1 Human genes 0.000 description 2
101710108924 Ribosomal protein S6 kinase beta-1 Proteins 0.000 description 2
YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
241000714474 Rous sarcoma virus Species 0.000 description 2
108020004682 Single-Stranded DNA Proteins 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
108091036066 Three prime untranslated region Proteins 0.000 description 2
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
239000004473 Threonine Substances 0.000 description 2
102100031027 Transcription activator BRG1 Human genes 0.000 description 2
101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
108010040002 Tumor Suppressor Proteins Proteins 0.000 description 2
102000001742 Tumor Suppressor Proteins Human genes 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
241000700605 Viruses Species 0.000 description 2
108700020467 WT1 Proteins 0.000 description 2
102100022748 Wilms tumor protein Human genes 0.000 description 2
PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
230000021736 acetylation Effects 0.000 description 2
238000006640 acetylation reaction Methods 0.000 description 2
208000009956 adenocarcinoma Diseases 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
238000010171 animal model Methods 0.000 description 2
230000003110 anti-inflammatory effect Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
235000009582 asparagine Nutrition 0.000 description 2
229960001230 asparagine Drugs 0.000 description 2
235000003704 aspartic acid Nutrition 0.000 description 2
201000009771 autoimmune polyendocrine syndrome type 1 Diseases 0.000 description 2
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
230000008236 biological pathway Effects 0.000 description 2
210000000625 blastula Anatomy 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
201000008275 breast carcinoma Diseases 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
230000036952 cancer formation Effects 0.000 description 2
238000005251 capillar electrophoresis Methods 0.000 description 2
230000012820 cell cycle checkpoint Effects 0.000 description 2
230000003915 cell function Effects 0.000 description 2
210000003169 central nervous system Anatomy 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
230000024321 chromosome segregation Effects 0.000 description 2
238000004590 computer program Methods 0.000 description 2
108091036078 conserved sequence Proteins 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000006378 damage Effects 0.000 description 2
230000007423 decrease Effects 0.000 description 2
230000007547 defect Effects 0.000 description 2
239000005547 deoxyribonucleotide Substances 0.000 description 2
125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
201000001981 dermatomyositis Diseases 0.000 description 2
238000013461 design Methods 0.000 description 2
239000000539 dimer Substances 0.000 description 2
208000016097 disease of metabolism Diseases 0.000 description 2
230000003828 downregulation Effects 0.000 description 2
238000007876 drug discovery Methods 0.000 description 2
239000003596 drug target Substances 0.000 description 2
230000013020 embryo development Effects 0.000 description 2
210000003038 endothelium Anatomy 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
210000000981 epithelium Anatomy 0.000 description 2
229960000403 etanercept Drugs 0.000 description 2
210000003002 eukaryotic large ribosome subunit Anatomy 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
102000054767 gene variant Human genes 0.000 description 2
208000016361 genetic disease Diseases 0.000 description 2
239000008103 glucose Substances 0.000 description 2
230000004153 glucose metabolism Effects 0.000 description 2
235000013922 glutamic acid Nutrition 0.000 description 2
239000004220 glutamic acid Substances 0.000 description 2
108010051239 glutaminyl-tRNA synthetase Proteins 0.000 description 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
229940029575 guanosine Drugs 0.000 description 2
210000002216 heart Anatomy 0.000 description 2
239000000833 heterodimer Substances 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
230000036737 immune function Effects 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
230000016784 immunoglobulin production Effects 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
239000000411 inducer Substances 0.000 description 2
230000028709 inflammatory response Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
229960000310 isoleucine Drugs 0.000 description 2
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
230000037356 lipid metabolism Effects 0.000 description 2
230000029226 lipidation Effects 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
210000001165 lymph node Anatomy 0.000 description 2
210000004698 lymphocyte Anatomy 0.000 description 2
239000006249 magnetic particle Substances 0.000 description 2
230000036212 malign transformation Effects 0.000 description 2
230000036210 malignancy Effects 0.000 description 2
230000003211 malignant effect Effects 0.000 description 2
239000002207 metabolite Substances 0.000 description 2
230000009401 metastasis Effects 0.000 description 2
206010061289 metastatic neoplasm Diseases 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
239000000178 monomer Substances 0.000 description 2
210000000066 myeloid cell Anatomy 0.000 description 2
201000000050 myeloid neoplasm Diseases 0.000 description 2
230000003448 neutrophilic effect Effects 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
230000008520 organization Effects 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
244000052769 pathogen Species 0.000 description 2
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 description 2
239000002574 poison Substances 0.000 description 2
231100000614 poison Toxicity 0.000 description 2
208000005987 polymyositis Diseases 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
230000001124 posttranscriptional effect Effects 0.000 description 2
230000001323 posttranslational effect Effects 0.000 description 2
230000002028 premature Effects 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000004393 prognosis Methods 0.000 description 2
230000035755 proliferation Effects 0.000 description 2
230000001915 proofreading effect Effects 0.000 description 2
230000001902 propagating effect Effects 0.000 description 2
150000003180 prostaglandins Chemical class 0.000 description 2
235000004252 protein component Nutrition 0.000 description 2
230000004850 protein–protein interaction Effects 0.000 description 2
230000006337 proteolytic cleavage Effects 0.000 description 2
108010049718 pseudouridine synthases Proteins 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000021014 regulation of cell growth Effects 0.000 description 2
230000014493 regulation of gene expression Effects 0.000 description 2
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
210000001202 rhombencephalon Anatomy 0.000 description 2
239000002342 ribonucleoside Substances 0.000 description 2
125000002652 ribonucleotide group Chemical group 0.000 description 2
238000011808 rodent model Methods 0.000 description 2
208000012672 seasonal affective disease Diseases 0.000 description 2
210000005212 secondary lymphoid organ Anatomy 0.000 description 2
230000011218 segmentation Effects 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
230000035939 shock Effects 0.000 description 2
210000002027 skeletal muscle Anatomy 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
208000000587 small cell lung carcinoma Diseases 0.000 description 2
210000001324 spliceosome Anatomy 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
230000001629 suppression Effects 0.000 description 2
230000009897 systematic effect Effects 0.000 description 2
229940037128 systemic glucocorticoids Drugs 0.000 description 2
208000001608 teratocarcinoma Diseases 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
108091006106 transcriptional activators Proteins 0.000 description 2
238000001890 transfection Methods 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
230000008733 trauma Effects 0.000 description 2
239000001226 triphosphate Substances 0.000 description 2
235000011178 triphosphate Nutrition 0.000 description 2
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
239000013603 viral vector Substances 0.000 description 2
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
108020004463 18S ribosomal RNA Proteins 0.000 description 1
PFCLMNDDPTZJHQ-XLPZGREQSA-N 2-amino-7-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PFCLMNDDPTZJHQ-XLPZGREQSA-N 0.000 description 1
QNIZHKITBISILC-RPKMEZRRSA-N 2-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-methyloxolan-2-yl]-3h-purin-6-one Chemical compound C1=NC(C(NC(N)=N2)=O)=C2N1[C@]1(C)O[C@H](CO)[C@@H](O)[C@H]1O QNIZHKITBISILC-RPKMEZRRSA-N 0.000 description 1
102100033714 40S ribosomal protein S6 Human genes 0.000 description 1
101710107638 40S ribosomal protein S6 Proteins 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
108020004565 5.8S Ribosomal RNA Proteins 0.000 description 1
102100024406 60S ribosomal protein L15 Human genes 0.000 description 1
102100021927 60S ribosomal protein L27a Human genes 0.000 description 1
102100030835 AT-rich interactive domain-containing protein 5B Human genes 0.000 description 1
101710081716 AT-rich interactive domain-containing protein 5B Proteins 0.000 description 1
102000021527 ATP binding proteins Human genes 0.000 description 1
108091011108 ATP binding proteins Proteins 0.000 description 1
108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
206010069754 Acquired gene mutation Diseases 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
206010000830 Acute leukaemia Diseases 0.000 description 1
108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
102100030446 Adenosine 5'-monophosphoramidase HINT1 Human genes 0.000 description 1
CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
108010025188 Alcohol oxidase Proteins 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
208000000044 Amnesia Diseases 0.000 description 1
208000031091 Amnestic disease Diseases 0.000 description 1
108090000663 Annexin A1 Proteins 0.000 description 1
102100040006 Annexin A1 Human genes 0.000 description 1
108090000656 Annexin A6 Proteins 0.000 description 1
102100034278 Annexin A6 Human genes 0.000 description 1
108700031308 Antennapedia Homeodomain Proteins 0.000 description 1
108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
208000019901 Anxiety disease Diseases 0.000 description 1
102000005666 Apolipoprotein A-I Human genes 0.000 description 1
108010059886 Apolipoprotein A-I Proteins 0.000 description 1
241000203069 Archaea Species 0.000 description 1
206010003210 Arteriosclerosis Diseases 0.000 description 1
208000012219 Autonomic Nervous System disease Diseases 0.000 description 1
208000003950 B-cell lymphoma Diseases 0.000 description 1
102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
108700040618 BRCA1 Genes Proteins 0.000 description 1
102000052609 BRCA2 Human genes 0.000 description 1
108700010154 BRCA2 Genes Proteins 0.000 description 1
108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 1
102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 1
108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 description 1
102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 description 1
201000000046 Beckwith-Wiedemann syndrome Diseases 0.000 description 1
OGBVRMYSNSKIEF-UHFFFAOYSA-N Benzylphosphonic acid Chemical class OP(O)(=O)CC1=CC=CC=C1 OGBVRMYSNSKIEF-UHFFFAOYSA-N 0.000 description 1
102100037674 Bis(5'-adenosyl)-triphosphatase Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
101000800130 Bos taurus Thyroglobulin Proteins 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
208000004020 Brain Abscess Diseases 0.000 description 1
206010048962 Brain oedema Diseases 0.000 description 1
208000011691 Burkitt lymphomas Diseases 0.000 description 1
206010006811 Bursitis Diseases 0.000 description 1
238000011740 C57BL/6 mouse Methods 0.000 description 1
101100423065 Caenorhabditis elegans dars-1 gene Proteins 0.000 description 1
101100252357 Caenorhabditis elegans rnp-1 gene Proteins 0.000 description 1
241000173351 Camvirus Species 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
108010031425 Casein Kinases Proteins 0.000 description 1
102000005403 Casein Kinases Human genes 0.000 description 1
241000701489 Cauliflower mosaic virus Species 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
101000709520 Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) Atypical response regulator protein ChxR Proteins 0.000 description 1
239000005496 Chlorsulfuron Substances 0.000 description 1
208000037088 Chromosome Breakage Diseases 0.000 description 1
206010053138 Congenital aplastic anaemia Diseases 0.000 description 1
241000709687 Coxsackievirus Species 0.000 description 1
208000019736 Cranial nerve disease Diseases 0.000 description 1
208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
239000004971 Cross linker Substances 0.000 description 1
208000014311 Cushing syndrome Diseases 0.000 description 1
102100026398 Cyclic AMP-responsive element-binding protein 3 Human genes 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
238000012270 DNA recombination Methods 0.000 description 1
102100030960 DNA replication licensing factor MCM2 Human genes 0.000 description 1
102100033711 DNA replication licensing factor MCM7 Human genes 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
102000052510 DNA-Binding Proteins Human genes 0.000 description 1
108700020911 DNA-Binding Proteins Proteins 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
102100036337 Dematin Human genes 0.000 description 1
101710088199 Dematin Proteins 0.000 description 1
206010012289 Dementia Diseases 0.000 description 1
208000016192 Demyelinating disease Diseases 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
208000032131 Diabetic Neuropathies Diseases 0.000 description 1
206010061818 Disease progression Diseases 0.000 description 1
108700030797 Drosophila caup Proteins 0.000 description 1
241000255601 Drosophila melanogaster Species 0.000 description 1
101100396397 Drosophila melanogaster eIF2gamma gene Proteins 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
102000014344 ELM2 domains Human genes 0.000 description 1
108050003378 ELM2 domains Proteins 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
241000701867 Enterobacteria phage T7 Species 0.000 description 1
102400001368 Epidermal growth factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
208000032027 Essential Thrombocythemia Diseases 0.000 description 1
102100038595 Estrogen receptor Human genes 0.000 description 1
108010056472 Eukaryotic Initiation Factor-4A Proteins 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
108091060211 Expressed sequence tag Proteins 0.000 description 1
206010061846 Extradural abscess Diseases 0.000 description 1
201000004939 Fanconi anemia Diseases 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
241000192125 Firmicutes Species 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
208000014770 Foot disease Diseases 0.000 description 1
102000005698 Frizzled receptors Human genes 0.000 description 1
108010045438 Frizzled receptors Proteins 0.000 description 1
201000011240 Frontotemporal dementia Diseases 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
102000034286 G proteins Human genes 0.000 description 1
108091006027 G proteins Proteins 0.000 description 1
230000004668 G2/M phase Effects 0.000 description 1
101710113436 GTPase KRas Proteins 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
230000010558 Gene Alterations Effects 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
208000034951 Genetic Translocation Diseases 0.000 description 1
208000003736 Gerstmann-Straussler-Scheinker Disease Diseases 0.000 description 1
206010072075 Gerstmann-Straussler-Scheinker syndrome Diseases 0.000 description 1
SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 1
QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 1
CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
108010015514 Glutamate-tRNA ligase Proteins 0.000 description 1
102100036646 Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Human genes 0.000 description 1
108010024636 Glutathione Proteins 0.000 description 1
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
108091027874 Group I catalytic intron Proteins 0.000 description 1
206010053759 Growth retardation Diseases 0.000 description 1
102000016285 Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
108010067218 Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
206010019695 Hepatic neoplasm Diseases 0.000 description 1
208000033640 Hereditary breast cancer Diseases 0.000 description 1
208000017095 Hereditary nonpolyposis colon cancer Diseases 0.000 description 1
108010034791 Heterochromatin Proteins 0.000 description 1
108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 1
102000017013 Heterogeneous Nuclear Ribonucleoprotein A1 Human genes 0.000 description 1
102000018802 High Mobility Group Proteins Human genes 0.000 description 1
108010052512 High Mobility Group Proteins Proteins 0.000 description 1
WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 1
WZOGEMJIZBNFBK-CIUDSAMLSA-N His-Asp-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O WZOGEMJIZBNFBK-CIUDSAMLSA-N 0.000 description 1
SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 1
YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
102000002061 Histidine triad (HIT) proteins Human genes 0.000 description 1
108050009489 Histidine triad (HIT) proteins Proteins 0.000 description 1
101710195459 Histidine triad nucleotide-binding protein Proteins 0.000 description 1
102100039869 Histone H2B type F-S Human genes 0.000 description 1
108090000353 Histone deacetylase Proteins 0.000 description 1
102000003964 Histone deacetylase Human genes 0.000 description 1
108050002855 Histone-lysine N-methyltransferase 2A Proteins 0.000 description 1
101000753696 Homo sapiens 60S ribosomal protein L27a Proteins 0.000 description 1
101000780137 Homo sapiens Annexin A6 Proteins 0.000 description 1
101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
101000855520 Homo sapiens Cyclic AMP-responsive element-binding protein 3 Proteins 0.000 description 1
101000583807 Homo sapiens DNA replication licensing factor MCM2 Proteins 0.000 description 1
101000830681 Homo sapiens DNA topoisomerase 1 Proteins 0.000 description 1
101001072655 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Proteins 0.000 description 1
101000990566 Homo sapiens HEAT repeat-containing protein 6 Proteins 0.000 description 1
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
101001035372 Homo sapiens Histone H2B type F-S Proteins 0.000 description 1
101000977765 Homo sapiens Iroquois-class homeodomain protein IRX-4 Proteins 0.000 description 1
101001050616 Homo sapiens KH domain-containing, RNA-binding, signal transduction-associated protein 1 Proteins 0.000 description 1
101000602930 Homo sapiens Nuclear receptor coactivator 2 Proteins 0.000 description 1
101000896765 Homo sapiens Peregrin Proteins 0.000 description 1
101000801684 Homo sapiens Phospholipid-transporting ATPase ABCA1 Proteins 0.000 description 1
101000720856 Homo sapiens Probable ATP-dependent RNA helicase DDX10 Proteins 0.000 description 1
101000919019 Homo sapiens Probable ATP-dependent RNA helicase DDX6 Proteins 0.000 description 1
101000892360 Homo sapiens Protein AF-17 Proteins 0.000 description 1
101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
101000666730 Homo sapiens T-complex protein 1 subunit alpha Proteins 0.000 description 1
101001074042 Homo sapiens Transcriptional activator GLI3 Proteins 0.000 description 1
101000759241 Homo sapiens Zinc finger protein 138 Proteins 0.000 description 1
101000744935 Homo sapiens Zinc finger protein 202 Proteins 0.000 description 1
101000788752 Homo sapiens Zinc finger protein 350 Proteins 0.000 description 1
101000964726 Homo sapiens Zinc finger protein 76 Proteins 0.000 description 1
101000743811 Homo sapiens Zinc finger protein 85 Proteins 0.000 description 1
101000743781 Homo sapiens Zinc finger protein 91 Proteins 0.000 description 1
101000785641 Homo sapiens Zinc finger protein with KRAB and SCAN domains 1 Proteins 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
208000023105 Huntington disease Diseases 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
206010060378 Hyperinsulinaemia Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010021024 Hypolipidaemia Diseases 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
USXAYNCLFSUSBA-MGHWNKPDSA-N Ile-Phe-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N USXAYNCLFSUSBA-MGHWNKPDSA-N 0.000 description 1
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
108020005350 Initiator Codon Proteins 0.000 description 1
108010001127 Insulin Receptor Proteins 0.000 description 1
102100036721 Insulin receptor Human genes 0.000 description 1
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
102000014429 Insulin-like growth factor Human genes 0.000 description 1
108010061833 Integrases Proteins 0.000 description 1
108090001007 Interleukin-8 Proteins 0.000 description 1
102400001355 Interleukin-8 Human genes 0.000 description 1
208000029523 Interstitial Lung disease Diseases 0.000 description 1
108010044467 Isoenzymes Proteins 0.000 description 1
102100036015 Isoleucine-tRNA ligase, cytoplasmic Human genes 0.000 description 1
101710176147 Isoleucine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
108010025815 Kanamycin Kinase Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
208000035752 Live birth Diseases 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
208000019693 Lung disease Diseases 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
108010062166 Lys-Asn-Asp Proteins 0.000 description 1
BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
208000000916 Mandibulofacial dysostosis Diseases 0.000 description 1
108091027974 Mature messenger RNA Proteins 0.000 description 1
241001599018 Melanogaster Species 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
206010027202 Meningitis bacterial Diseases 0.000 description 1
206010027260 Meningitis viral Diseases 0.000 description 1
208000036626 Mental retardation Diseases 0.000 description 1
206010068836 Metabolic myopathy Diseases 0.000 description 1
101710133025 Metastasis-associated protein MTA1 Proteins 0.000 description 1
101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
102000016397 Methyltransferase Human genes 0.000 description 1
208000032818 Microsatellite Instability Diseases 0.000 description 1
108010006519 Molecular Chaperones Proteins 0.000 description 1
208000019022 Mood disease Diseases 0.000 description 1
102000007474 Multiprotein Complexes Human genes 0.000 description 1
108010085220 Multiprotein Complexes Proteins 0.000 description 1
241000714177 Murine leukemia virus Species 0.000 description 1
101100381525 Mus musculus Bcl6 gene Proteins 0.000 description 1
101100126279 Mus musculus Irx4 gene Proteins 0.000 description 1
101100129245 Mus musculus Mafb gene Proteins 0.000 description 1
101000753272 Mus musculus Transcription intermediary factor 1-beta Proteins 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
208000003926 Myelitis Diseases 0.000 description 1
102100038610 Myeloperoxidase Human genes 0.000 description 1
108090000235 Myeloperoxidases Proteins 0.000 description 1
206010028643 Myopathy endocrine Diseases 0.000 description 1
206010028648 Myopathy toxic Diseases 0.000 description 1
208000023137 Myotoxicity Diseases 0.000 description 1
RSPURTUNRHNVGF-IOSLPCCCSA-N N(2),N(2)-dimethylguanosine Chemical compound C1=NC=2C(=O)NC(N(C)C)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RSPURTUNRHNVGF-IOSLPCCCSA-N 0.000 description 1
241000244206 Nematoda Species 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
206010029260 Neuroblastoma Diseases 0.000 description 1
208000009905 Neurofibromatoses Diseases 0.000 description 1
241000221961 Neurospora crassa Species 0.000 description 1
108020004485 Nonsense Codon Proteins 0.000 description 1
102000043141 Nuclear RNA Human genes 0.000 description 1
108020003217 Nuclear RNA Proteins 0.000 description 1
108020005497 Nuclear hormone receptor Proteins 0.000 description 1
102100025372 Nuclear pore complex protein Nup98-Nup96 Human genes 0.000 description 1
108090000163 Nuclear pore complex proteins Proteins 0.000 description 1
102000003789 Nuclear pore complex proteins Human genes 0.000 description 1
102100037226 Nuclear receptor coactivator 2 Human genes 0.000 description 1
102000011931 Nucleoproteins Human genes 0.000 description 1
108010061100 Nucleoproteins Proteins 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
208000007571 Ovarian Epithelial Carcinoma Diseases 0.000 description 1
238000009004 PCR Kit Methods 0.000 description 1
201000011392 Pallister-Hall syndrome Diseases 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
208000027099 Paranoid disease Diseases 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
229920002352 Peptidyl-tRNA Polymers 0.000 description 1
101710139635 Peregrin Proteins 0.000 description 1
102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 1
108090000472 Phosphoenolpyruvate carboxykinase (ATP) Proteins 0.000 description 1
102100034792 Phosphoenolpyruvate carboxykinase [GTP], mitochondrial Human genes 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
241000235648 Pichia Species 0.000 description 1
208000000609 Pick Disease of the Brain Diseases 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
102100039427 Polyadenylate-binding protein 2 Human genes 0.000 description 1
206010036049 Polycystic ovaries Diseases 0.000 description 1
229920000388 Polyphosphate Polymers 0.000 description 1
206010036376 Postherpetic Neuralgia Diseases 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
102000029797 Prion Human genes 0.000 description 1
108091000054 Prion Proteins 0.000 description 1
208000024777 Prion disease Diseases 0.000 description 1
102100025897 Probable ATP-dependent RNA helicase DDX10 Human genes 0.000 description 1
101710149031 Probable isoleucine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
101710146427 Probable tyrosine-tRNA ligase, cytoplasmic Proteins 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102100026126 Proline-tRNA ligase Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
101710150114 Protein rep Proteins 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
108700020978 Proto-Oncogene Proteins 0.000 description 1
102000052575 Proto-Oncogene Human genes 0.000 description 1
102100037894 Proto-oncogene c-Rel Human genes 0.000 description 1
108050003226 Proto-oncogene c-Rel Proteins 0.000 description 1
229930185560 Pseudouridine Natural products 0.000 description 1
PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 1
108030005599 Pseudouridylate synthases Proteins 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
102000017143 RNA Polymerase I Human genes 0.000 description 1
108010013845 RNA Polymerase I Proteins 0.000 description 1
102000009572 RNA Polymerase II Human genes 0.000 description 1
108010009460 RNA Polymerase II Proteins 0.000 description 1
102000014450 RNA Polymerase III Human genes 0.000 description 1
108010078067 RNA Polymerase III Proteins 0.000 description 1
108020004518 RNA Probes Proteins 0.000 description 1
102000015097 RNA Splicing Factors Human genes 0.000 description 1
108010039259 RNA Splicing Factors Proteins 0.000 description 1
108091008103 RNA aptamers Proteins 0.000 description 1
238000010357 RNA editing Methods 0.000 description 1
230000026279 RNA modification Effects 0.000 description 1
239000003391 RNA probe Substances 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
102000044126 RNA-Binding Proteins Human genes 0.000 description 1
108700020471 RNA-Binding Proteins Proteins 0.000 description 1
206010037779 Radiculopathy Diseases 0.000 description 1
101100473045 Rattus norvegicus Hnrnpa2b1 gene Proteins 0.000 description 1
102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
208000001647 Renal Insufficiency Diseases 0.000 description 1
101710152114 Replication protein Proteins 0.000 description 1
208000017442 Retinal disease Diseases 0.000 description 1
208000007014 Retinitis pigmentosa Diseases 0.000 description 1
201000000582 Retinoblastoma Diseases 0.000 description 1
206010038923 Retinopathy Diseases 0.000 description 1
208000025747 Rheumatic disease Diseases 0.000 description 1
102000004167 Ribonuclease P Human genes 0.000 description 1
108090000621 Ribonuclease P Proteins 0.000 description 1
108090000983 Ribosomal protein L15 Proteins 0.000 description 1
102100024917 Ribosomal protein S6 kinase beta-2 Human genes 0.000 description 1
101710108923 Ribosomal protein S6 kinase beta-2 Proteins 0.000 description 1
108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
102000013674 S-100 Human genes 0.000 description 1
MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 description 1
108700021018 S100 Proteins 0.000 description 1
108010005173 SERPIN-B5 Proteins 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
201000010208 Seminoma Diseases 0.000 description 1
108091081021 Sense strand Proteins 0.000 description 1
VQBLHWSPVYYZTB-DCAQKATOSA-N Ser-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N VQBLHWSPVYYZTB-DCAQKATOSA-N 0.000 description 1
CDVFZMOFNJPUDD-ACZMJKKPSA-N Ser-Gln-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O CDVFZMOFNJPUDD-ACZMJKKPSA-N 0.000 description 1
102100030333 Serpin B5 Human genes 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
108091027076 Spiegelmer Proteins 0.000 description 1
208000029033 Spinal Cord disease Diseases 0.000 description 1
208000010112 Spinocerebellar Degenerations Diseases 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
206010042265 Sturge-Weber Syndrome Diseases 0.000 description 1
201000000002 Subdural Empyema Diseases 0.000 description 1
241000282887 Suidae Species 0.000 description 1
201000009594 Systemic Scleroderma Diseases 0.000 description 1
206010042953 Systemic sclerosis Diseases 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
101150094934 TCS gene Proteins 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
206010043118 Tardive Dyskinesia Diseases 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
108010000499 Thromboplastin Proteins 0.000 description 1
102000002262 Thromboplastin Human genes 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
102000006601 Thymidine Kinase Human genes 0.000 description 1
108020004440 Thymidine kinase Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
208000000323 Tourette Syndrome Diseases 0.000 description 1
208000016620 Tourette disease Diseases 0.000 description 1
201000003379 Townes-Brocks syndrome Diseases 0.000 description 1
108010018242 Transcription Factor AP-1 Proteins 0.000 description 1
108010031154 Transcription Factor RelA Proteins 0.000 description 1
102100023132 Transcription factor Jun Human genes 0.000 description 1
102100032727 Transcription factor RelB Human genes 0.000 description 1
108090000952 Transcription factor RelB Proteins 0.000 description 1
102100035100 Transcription factor p65 Human genes 0.000 description 1
102100022012 Transcription intermediary factor 1-beta Human genes 0.000 description 1
101710177718 Transcription intermediary factor 1-beta Proteins 0.000 description 1
201000003199 Treacher Collins syndrome Diseases 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
SWSUXOKZKQRADK-FDARSICLSA-N Trp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SWSUXOKZKQRADK-FDARSICLSA-N 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
208000026911 Tuberous sclerosis complex Diseases 0.000 description 1
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
KWKJGBHDYJOVCR-SRVKXCTJSA-N Tyr-Ser-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O KWKJGBHDYJOVCR-SRVKXCTJSA-N 0.000 description 1
AFWXOGHZEKARFH-ACRUOGEOSA-N Tyr-Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 AFWXOGHZEKARFH-ACRUOGEOSA-N 0.000 description 1
102100025336 Tyrosine-tRNA ligase, mitochondrial Human genes 0.000 description 1
101710107268 Tyrosine-tRNA ligase, mitochondrial Proteins 0.000 description 1
229910052770 Uranium Inorganic materials 0.000 description 1
GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
206010051512 Viral myositis Diseases 0.000 description 1
IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
206010049644 Williams syndrome Diseases 0.000 description 1
108050003627 Wnt Proteins 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
241000269368 Xenopus laevis Species 0.000 description 1
101000759263 Xenopus laevis Zinc finger protein 143 Proteins 0.000 description 1
102100023394 Zinc finger protein 138 Human genes 0.000 description 1
102100040710 Zinc finger protein 76 Human genes 0.000 description 1
102100039050 Zinc finger protein 85 Human genes 0.000 description 1
102100026463 Zinc finger protein with KRAB and SCAN domains 1 Human genes 0.000 description 1
108091007916 Zinc finger transcription factors Proteins 0.000 description 1
102000038627 Zinc finger transcription factors Human genes 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
208000017733 acquired polycythemia vera Diseases 0.000 description 1
108091000387 actin binding proteins Proteins 0.000 description 1
208000009621 actinic keratosis Diseases 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
239000012082 adaptor molecule Substances 0.000 description 1
210000000593 adipose tissue white Anatomy 0.000 description 1
208000024447 adrenal gland neoplasm Diseases 0.000 description 1
230000032683 aging Effects 0.000 description 1
108010047495 alanylglycine Proteins 0.000 description 1
PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical group OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
239000013566 allergen Substances 0.000 description 1
230000004075 alteration Effects 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
230000006986 amnesia Effects 0.000 description 1
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
208000036878 aneuploidy Diseases 0.000 description 1
239000004410 anthocyanin Substances 0.000 description 1
229930002877 anthocyanin Natural products 0.000 description 1
235000010208 anthocyanin Nutrition 0.000 description 1
150000004636 anthocyanins Chemical class 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
210000000612 antigen-presenting cell Anatomy 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
239000000074 antisense oligonucleotide Substances 0.000 description 1
238000012230 antisense oligonucleotides Methods 0.000 description 1
230000036506 anxiety Effects 0.000 description 1
210000002403 aortic endothelial cell Anatomy 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
229940114079 arachidonic acid Drugs 0.000 description 1
235000021342 arachidonic acid Nutrition 0.000 description 1
208000011775 arteriosclerosis disease Diseases 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
210000001106 artificial yeast chromosome Anatomy 0.000 description 1
125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
230000006472 autoimmune response Effects 0.000 description 1
208000021018 autosomal dominant inheritance Diseases 0.000 description 1
102000039554 bZIP family Human genes 0.000 description 1
108091067354 bZIP family Proteins 0.000 description 1
201000009904 bacterial meningitis Diseases 0.000 description 1
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
208000018300 basal ganglia disease Diseases 0.000 description 1
239000011324 bead Substances 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
238000011953 bioanalysis Methods 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
108010005713 bis(5'-adenosyl)triphosphatase Proteins 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
208000006752 brain edema Diseases 0.000 description 1
210000000984 branchial region Anatomy 0.000 description 1
210000000069 breast epithelial cell Anatomy 0.000 description 1
238000009395 breeding Methods 0.000 description 1
230000001488 breeding effect Effects 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
230000021523 carboxylation Effects 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
230000003293 cardioprotective effect Effects 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
206010007776 catatonia Diseases 0.000 description 1
230000008568 cell cell communication Effects 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000006721 cell death pathway Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000032341 cell morphogenesis Effects 0.000 description 1
230000009087 cell motility Effects 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
230000002032 cellular defenses Effects 0.000 description 1
230000030570 cellular localization Effects 0.000 description 1
230000033077 cellular process Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
208000015114 central nervous system disease Diseases 0.000 description 1
206010008129 cerebral palsy Diseases 0.000 description 1
208000026106 cerebrovascular disease Diseases 0.000 description 1
210000003679 cervix uteri Anatomy 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000013522 chelant Substances 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
239000007806 chemical reaction intermediate Substances 0.000 description 1
239000005081 chemiluminescent agent Substances 0.000 description 1
230000035605 chemotaxis Effects 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
150000001840 cholesterol esters Chemical class 0.000 description 1
108091006090 chromatin-associated proteins Proteins 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000007882 cirrhosis Effects 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
208000029664 classic familial adenomatous polyposis Diseases 0.000 description 1
230000010405 clearance mechanism Effects 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
238000012875 competitive assay Methods 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000030944 contact inhibition Effects 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
208000014826 cranial nerve neuropathy Diseases 0.000 description 1
230000008226 craniofacial development Effects 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
238000009402 cross-breeding Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
150000001945 cysteines Chemical class 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
108091007930 cytoplasmic receptors Proteins 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
210000004292 cytoskeleton Anatomy 0.000 description 1
230000007123 defense Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
230000002074 deregulated effect Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
230000009547 development abnormality Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
230000009274 differential gene expression Effects 0.000 description 1
210000002249 digestive system Anatomy 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
230000005750 disease progression Effects 0.000 description 1
208000037765 diseases and disorders Diseases 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
229960004679 doxorubicin Drugs 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000012912 drug discovery process Methods 0.000 description 1
208000010118 dystonia Diseases 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
210000003981 ectoderm Anatomy 0.000 description 1
230000005014 ectopic expression Effects 0.000 description 1
239000012636 effector Substances 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
229940073621 enbrel Drugs 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
210000001900 endoderm Anatomy 0.000 description 1
239000006274 endogenous ligand Substances 0.000 description 1
230000002616 endonucleolytic effect Effects 0.000 description 1
210000003989 endothelium vascular Anatomy 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
201000000165 epidural abscess Diseases 0.000 description 1
206010015037 epilepsy Diseases 0.000 description 1
108010038795 estrogen receptors Proteins 0.000 description 1
230000010429 evolutionary process Effects 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
201000006061 fatal familial insomnia Diseases 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
201000010255 female reproductive organ cancer Diseases 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
239000000835 fiber Substances 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
230000004907 flux Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000006062 fragmentation reaction Methods 0.000 description 1
230000004927 fusion Effects 0.000 description 1
210000000232 gallbladder Anatomy 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
210000000609 ganglia Anatomy 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000011223 gene expression profiling Methods 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
230000008571 general function Effects 0.000 description 1
230000009395 genetic defect Effects 0.000 description 1
230000030414 genetic transfer Effects 0.000 description 1
230000007614 genetic variation Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000004110 gluconeogenesis Effects 0.000 description 1
108010040856 glutamyl-cysteinyl-alanine Proteins 0.000 description 1
229960003180 glutathione Drugs 0.000 description 1
210000003714 granulocyte Anatomy 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
231100000001 growth retardation Toxicity 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
230000009067 heart development Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
210000001308 heart ventricle Anatomy 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
230000010224 hepatic metabolism Effects 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
206010073071 hepatocellular carcinoma Diseases 0.000 description 1
210000003494 hepatocyte Anatomy 0.000 description 1
230000002363 herbicidal effect Effects 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
208000025581 hereditary breast carcinoma Diseases 0.000 description 1
210000004458 heterochromatin Anatomy 0.000 description 1
101150113423 hisD gene Proteins 0.000 description 1
108700039582 histidine triad Proteins 0.000 description 1
102000056970 human DDX6 Human genes 0.000 description 1
102000053860 human IRX4 Human genes 0.000 description 1
102000056859 human TOP1 Human genes 0.000 description 1
102000044897 human ZNF350 Human genes 0.000 description 1
102000054622 human ZNF91 Human genes 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
208000013403 hyperactivity Diseases 0.000 description 1
201000001421 hyperglycemia Diseases 0.000 description 1
230000003451 hyperinsulinaemic effect Effects 0.000 description 1
201000008980 hyperinsulinism Diseases 0.000 description 1
208000029498 hypoalphalipoproteinemia Diseases 0.000 description 1
208000026278 immune system disease Diseases 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
230000032561 inner ear development Effects 0.000 description 1
230000003914 insulin secretion Effects 0.000 description 1
230000010354 integration Effects 0.000 description 1
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
229940096397 interleukin-8 Drugs 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
230000006662 intracellular pathway Effects 0.000 description 1
238000007917 intracranial administration Methods 0.000 description 1
208000030776 invasive breast carcinoma Diseases 0.000 description 1
238000007852 inverse PCR Methods 0.000 description 1
JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000000302 ischemic effect Effects 0.000 description 1
201000006370 kidney failure Diseases 0.000 description 1
238000011813 knockout mouse model Methods 0.000 description 1
206010023497 kuru Diseases 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
208000003849 large cell carcinoma Diseases 0.000 description 1
210000002429 large intestine Anatomy 0.000 description 1
230000011268 leukocyte chemotaxis Effects 0.000 description 1
150000002617 leukotrienes Chemical class 0.000 description 1
210000000982 limb bud Anatomy 0.000 description 1
230000006517 limb development Effects 0.000 description 1
230000013190 lipid storage Effects 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
206010024627 liposarcoma Diseases 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
208000014018 liver neoplasm Diseases 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000006166 lysate Substances 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
230000005291 magnetic effect Effects 0.000 description 1
230000031852 maintenance of location in cell Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
210000003519 mature b lymphocyte Anatomy 0.000 description 1
239000002609 medium Substances 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
210000003716 mesoderm Anatomy 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229910021645 metal ion Inorganic materials 0.000 description 1
230000001394 metastastic effect Effects 0.000 description 1
208000011645 metastatic carcinoma Diseases 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
230000033607 mismatch repair Effects 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
230000028550 monocyte chemotaxis Effects 0.000 description 1
230000036651 mood Effects 0.000 description 1
208000005264 motor neuron disease Diseases 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
238000002887 multiple sequence alignment Methods 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000002464 muscle smooth vascular Anatomy 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
206010028417 myasthenia gravis Diseases 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
239000006225 natural substrate Substances 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
208000018389 neoplasm of cerebral hemisphere Diseases 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
210000000653 nervous system Anatomy 0.000 description 1
210000003061 neural cell Anatomy 0.000 description 1
230000003988 neural development Effects 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
201000004931 neurofibromatosis Diseases 0.000 description 1
230000004766 neurogenesis Effects 0.000 description 1
230000001272 neurogenic effect Effects 0.000 description 1
208000018360 neuromuscular disease Diseases 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
230000008779 noncanonical pathway Effects 0.000 description 1
230000037434 nonsense mutation Effects 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
108010054452 nuclear pore complex protein 98 Proteins 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
125000003835 nucleoside group Chemical group 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000003921 oil Substances 0.000 description 1
238000006384 oligomerization reaction Methods 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
229920002842 oligophosphate Polymers 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000008816 organ damage Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000008212 organismal development Effects 0.000 description 1
230000004792 oxidative damage Effects 0.000 description 1
229940094443 oxytocics prostaglandins Drugs 0.000 description 1
230000010765 pachytene Effects 0.000 description 1
210000002741 palatine tonsil Anatomy 0.000 description 1
230000000849 parathyroid Effects 0.000 description 1
201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
230000001991 pathophysiological effect Effects 0.000 description 1
230000035778 pathophysiological process Effects 0.000 description 1
230000006320 pegylation Effects 0.000 description 1
210000003899 penis Anatomy 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
208000029308 periodic paralysis Diseases 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
208000027232 peripheral nervous system disease Diseases 0.000 description 1
208000033808 peripheral neuropathy Diseases 0.000 description 1
210000001986 peyer's patch Anatomy 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
230000003285 pharmacodynamic effect Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
BQVCCPGCDUSGOE-UHFFFAOYSA-N phenylarsine oxide Chemical compound O=[As]C1=CC=CC=C1 BQVCCPGCDUSGOE-UHFFFAOYSA-N 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
230000002186 photoactivation Effects 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
229960005095 pioglitazone Drugs 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
230000001402 polyadenylating effect Effects 0.000 description 1
201000010065 polycystic ovary syndrome Diseases 0.000 description 1
208000037244 polycythemia vera Diseases 0.000 description 1
239000001205 polyphosphate Substances 0.000 description 1
235000011176 polyphosphates Nutrition 0.000 description 1
208000015768 polyposis Diseases 0.000 description 1
238000010837 poor prognosis Methods 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
208000028681 postaxial polydactyly type A Diseases 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
238000002953 preparative HPLC Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000000861 pro-apoptotic effect Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
208000023958 prostate neoplasm Diseases 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000004952 protein activity Effects 0.000 description 1
230000012846 protein folding Effects 0.000 description 1
230000004853 protein function Effects 0.000 description 1
230000018883 protein targeting Effects 0.000 description 1
230000003161 proteinsynthetic effect Effects 0.000 description 1
PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
239000002213 purine nucleotide Substances 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000006340 racemization Effects 0.000 description 1
206010061928 radiculitis Diseases 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000009790 rate-determining step (RDS) Methods 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
108700015048 receptor decoy activity proteins Proteins 0.000 description 1
230000007115 recruitment Effects 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
230000007261 regionalization Effects 0.000 description 1
230000023252 regulation of cell development Effects 0.000 description 1
230000009712 regulation of translation Effects 0.000 description 1
201000010384 renal tubular acidosis Diseases 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
201000006845 reticulosarcoma Diseases 0.000 description 1
208000029922 reticulum cell sarcoma Diseases 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
230000004141 reverse cholesterol transport Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
201000003068 rheumatic fever Diseases 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
230000028710 ribosome assembly Effects 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
229960004586 rosiglitazone Drugs 0.000 description 1
210000003079 salivary gland Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
201000000980 schizophrenia Diseases 0.000 description 1
238000007789 sealing Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000005204 segregation Methods 0.000 description 1
238000010187 selection method Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
230000020509 sex determination Effects 0.000 description 1
230000005783 single-strand break Effects 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
210000000813 small intestine Anatomy 0.000 description 1
239000000779 smoke Substances 0.000 description 1
230000000391 smoking effect Effects 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
230000037439 somatic mutation Effects 0.000 description 1
230000021595 spermatogenesis Effects 0.000 description 1
210000003594 spinal ganglia Anatomy 0.000 description 1
230000027039 spliceosomal complex assembly Effects 0.000 description 1
208000028882 split hand Diseases 0.000 description 1
206010041823 squamous cell carcinoma Diseases 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000035882 stress Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
201000000596 systemic lupus erythematosus Diseases 0.000 description 1
230000014626 tRNA modification Effects 0.000 description 1
108091064493 tRNA uridine Proteins 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
229940094937 thioredoxin Drugs 0.000 description 1
201000005060 thrombophlebitis Diseases 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
238000012090 tissue culture technique Methods 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
235000019505 tobacco product Nutrition 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
238000007056 transamidation reaction Methods 0.000 description 1
108091008023 transcriptional regulators Proteins 0.000 description 1
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
101150081616 trpB gene Proteins 0.000 description 1
101150111232 trpB-1 gene Proteins 0.000 description 1
208000009999 tuberous sclerosis Diseases 0.000 description 1
230000005747 tumor angiogenesis Effects 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
239000000225 tumor suppressor protein Substances 0.000 description 1
230000005760 tumorsuppression Effects 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
210000003932 urinary bladder Anatomy 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000006442 vascular tone Effects 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
230000002861 ventricular Effects 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
108090000195 villin Proteins 0.000 description 1
OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
229960004528 vincristine Drugs 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
201000010044 viral meningitis Diseases 0.000 description 1
235000012431 wafers Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Zoology (AREA)
Microbiology (AREA)
Neurosurgery (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Dermatology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Oncology (AREA)
Toxicology (AREA)
Communicable Diseases (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)

CA002462660A 2001-10-29 2002-10-29 Nucleic acid-associated proteins Abandoned CA2462660A1 (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
US34844201P	2001-10-29	2001-10-29
US60/348,442		2001-10-29
US33554401P	2001-11-01	2001-11-01
US60/335,544		2001-11-01
US33753501P	2001-11-05	2001-11-05
US60/337,535		2001-11-05
US34465001P	2001-11-09	2001-11-09
US60/344,650		2001-11-09
US33476201P	2001-11-15	2001-11-15
US60/334,762		2001-11-15
PCT/US2002/034846 WO2003038052A2 (en)	2001-10-29	2002-10-29	Nucleic acid-associated proteins

Publications (1)

Publication Number	Publication Date
CA2462660A1 true CA2462660A1 (en)	2003-05-08

Family

ID=27541124

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002462660A Abandoned CA2462660A1 (en)	2001-10-29	2002-10-29	Nucleic acid-associated proteins

Country Status (5)

Country	Link
EP (1)	EP1497315A2 (de)
JP (1)	JP2005508636A (de)
AU (1)	AU2002359333A1 (de)
CA (1)	CA2462660A1 (de)
WO (1)	WO2003038052A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1402053A4 (de) *	2001-06-05	2005-05-11	Exelixis Inc	Chds als modifikatoren des p53-wegs und verwendungsverfahren
US8497101B2 (en) *	2005-05-13	2013-07-30	Centre National De La Recherche Scientifique (Cnrs)	Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions
GEP20156313B (en)	2010-09-22	2015-07-10	Alios Biopharma Inc	Substituted nucleotide analogs
US8980865B2 (en)	2011-12-22	2015-03-17	Alios Biopharma, Inc.	Substituted nucleotide analogs
US8916538B2 (en)	2012-03-21	2014-12-23	Vertex Pharmaceuticals Incorporated	Solid forms of a thiophosphoramidate nucleotide prodrug
EP2827876A4 (de)	2012-03-22	2015-10-28	Alios Biopharma Inc	Pharmazeutische kombinationen mit einem thionucleotidanalog

2002
- 2002-10-29 WO PCT/US2002/034846 patent/WO2003038052A2/en not_active Ceased
- 2002-10-29 AU AU2002359333A patent/AU2002359333A1/en not_active Abandoned
- 2002-10-29 CA CA002462660A patent/CA2462660A1/en not_active Abandoned
- 2002-10-29 JP JP2003540317A patent/JP2005508636A/ja active Pending
- 2002-10-29 EP EP02793861A patent/EP1497315A2/de not_active Withdrawn

Also Published As

Publication number	Publication date
WO2003038052A3 (en)	2004-11-11
WO2003038052A2 (en)	2003-05-08
AU2002359333A1 (en)	2003-05-12
EP1497315A2 (de)	2005-01-19
JP2005508636A (ja)	2005-04-07

Legal Events

Date	Code	Title	Description
2005-10-31	FZDE	Dead

Publication	Publication Date	Title
WO2004087875A2 (en)	2004-10-14	Nucleic acid-associated proteins
WO2003094848A2 (en)	2003-11-20	Nucleic acid-associated proteins
EP1506304A2 (de)	2005-02-16	Mit nukleinsäure assoziierte proteine
CA2449440A1 (en)	2002-12-19	Structural and cytoskeleton-associated proteins
WO2003076586A2 (en)	2003-09-18	Nucleic acid-associated proteins
US20040137448A1 (en)	2004-07-15	Nucleic acid-associated proteins
WO2003077875A2 (en)	2003-09-25	Proteins associated with growth, differentiation, and death
CA2449272A1 (en)	2002-12-19	Intracellular signaling molecules
CA2463000A1 (en)	2003-08-07	Vesicle-associated proteins
WO2003038052A2 (en)	2003-05-08	Nucleic acid-associated proteins
WO2004031364A2 (en)	2004-04-15	Proteins associated with cell growth, differentiation, and death
WO2003010329A2 (en)	2003-02-06	Nucleic acid-associated proteins
WO2003095622A2 (en)	2003-11-20	Proteins associated with cell growth, differentiation, and death
WO2004015396A2 (en)	2004-02-19	Cell adhesion and extracellular matrix proteins
EP1392852A2 (de)	2004-03-03	Nukleinsäureassoziierte proteine
US20050118582A1 (en)	2005-06-02	Nucleic acid-associated proteins
WO2003094843A2 (en)	2003-11-20	Cell adhesion and extracellular matrix proteins
EP1434788A2 (de)	2004-07-07	Proteine, assoziert mit zellwachstum, diffenzierung und tod
US20050186569A1 (en)	2005-08-25	Nucleic acid-associated proteins
WO2003052048A2 (en)	2003-06-26	Nucleic acid-associated proteins
WO2004067712A2 (en)	2004-08-12	Intracellular signaling molecules
WO2004011604A2 (en)	2004-02-05	Nucleic acid-associated proteins
WO2002079389A2 (en)	2002-10-10	Nucleic acid-associated proteins
WO2003046151A2 (en)	2003-06-05	Nucleic acid-associated proteins
WO2002050279A2 (en)	2002-06-27	Nucleic acid-associated proteins